A Trial of Licartin for Preventing Tumor Recurrence After Liver Resection
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to analyze the therapeutic effect of adjuvant Licartin therapy after
resection.Patients receiving curative resection (R0) were randomized to postoperative
Licartin group and no Licartin group. The time to recurrence ,the overall survival as well as
the incidence of complications after therapy was observed to confirm the role of adjuvant
therapy of Licartin.